Atea Pharmaceuticals (NASDAQ:AVIR) used its presentation at the 44th Annual JPMorgan Healthcare Conference to provide updates ...

A three-dose vaccine regimen prevented hepatitis E virus (HEV) infections with high efficacy in adults over the course of 10 years, a phase III trial from China found. The HEV239 vaccine, sold under ...

Please provide your email address to receive an email when new articles are posted on . From a public health point of view, there are no specific strategies for prevention of hepatitis E virus ...

Dr. Reddy’s launches Hevaxin, India’s first approved vaccine for preventing Hepatitis E virus infection in adults aged 18 to ...

The hepatitis E virus (HEV) is among the leading global causes of acute viral hepatitis. Molecular studies of HEV strains have identified four main genotypes. Genotypes 1 and 2 are limited to humans ...

A hepatitis E-positive meat product appears to be behind most of the infections that occurred earlier this year in Finland. The hepatitis E virus previously detected in sausages from a domestic ...

In the quiet corners of our hospital wards and bustling OPDs, a silent yet deadly disease continues to claim thousands of lives every year. Viral hepatitis remains one of India’s biggest but least ...

For the second time this month, Roche is launching a new immunoassay to help diagnose cases of hepatitis. This time around, the newly unveiled test is one designed to identify the hepatitis B e ...

HEV causes acute liver disease in humans, affecting mostly young people in endemic areas. The fatality rate of HEV infection is very low (~0.1%) when individuals are immunocompetent. HEV infection is ...